甲状腺激素抵抗β型患者肝脂肪含量增加
本研究对比21名THRB基因R243Q突变所致甲状腺激素抵抗β型(RTHβ)患者与22名野生型一级亲属,采用FibroScan检测受控衰减参数(CAP)。结果发现RTHβ组肝脂肪含量显著高于野生型(CAP 263±21 vs 218.7±43 dB/m,p=0.007),且CAP值与年龄、BMI的相关性仅在野生型中存在,提示TRβ信号缺陷对肝脂肪变性的影响超过年龄和肥胖因素。
要点
- RTHβ患者肝脂肪含量显著高于野生型亲属,CAP值263 vs 218.7 dB/m。
- RTHβ患者游离脂肪酸水平显著升高(0.29 vs 0.17 mmol/L)。
- RTHβ患者CAP值与年龄、BMI不相关,提示TRβ信号缺陷为主导因素。
核心结论
- THRB基因突变导致肝内TRβ信号受损,可引发肝脂肪变性。
- 研究结果为开发TRβ选择性甲状腺模拟物治疗脂质性肝病提供了依据。
研究设计与样本
- 病例对照研究,纳入21名THRB基因R243Q突变携带者及22名野生型一级亲属。
- 所有参与者来自同一家族、居住于同一小岛,环境因素相似。
- 采用超声瞬时弹性成像设备(FibroScan)检测受控衰减参数(CAP),过夜空腹后采血,观察者设盲。
主要发现
- RTHβ组CAP值显著高于野生型组(263±21 vs 218.7±43 dB/m,p=0.007)。
- 野生型亲属中CAP值与年龄(r=0.55,p=0.011)及BMI(r=0.51,p=0.022)相关,RTHβ组无此相关性。
- RTHβ组循环游离脂肪酸水平显著高于野生型组(0.29±0.033 vs 0.17±0.025 mmol/L,p=0.02)。
- 两组经稳态模型评估的胰岛素抵抗均无证据。
临床怎么用
- 对RTHβ患者应关注肝脂肪变性风险,可考虑无创肝脂肪定量评估。
- TRβ选择性甲状腺模拟物可能成为脂质性肝病(尤其是非酒精性脂肪性肝病)的潜在治疗方向。
局限性
- 样本量较小(RTHβ组21例,野生型组22例),且为同一家族单一家系研究。
- 采用CAP评估肝脂肪含量,未报告肝活检病理结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Thyroid hormone (TH) has important functions in controlling hepatic lipid metabolism. Individuals with resistance to thyroid hormone beta (RTHβ) who harbor mutations in the THRB gene experience loss-of-function of thyroid hormone receptor beta (TRβ), which is the predominant TR isoform expressed in the liver. We hypothesized that individuals with RTHβ may have increased hepatic steatosis. Methods: Controlled attenuation parameter (CAP) was assessed in individuals harboring the R243Q mutation of the THRB gene (n = 21) and in their wild-type (WT) first-degree relatives (n = 22) using the ultrasound-based transient elastography (TE) device (FibroScan). All participants belonged to the same family, lived on the same small island, and were therefore exposed to similar environmental conditions. CAP measurements and blood samples were obtained after an overnight fast. The observers were blinded to the status of the patients. Results: The hepatic fat content was increased in RTHβ individuals compared with their WT relatives (CAP values of 263 ± 21 and 218.7 ± 43 dB/m, respectively, p = 0.007). The CAP values correlated with age and body mass index (BMI) (age: r = 0.55, p = 0.011; BMI: r = 0.51, p = 0.022) in the WT first-degree relatives but not in RTHβ individuals, suggesting that the defect in TRβ signaling was predominant over the effects of age and obesity. Circulating free fatty acid levels were significantly higher in RTHβ individuals (0.29 ± 0.033 vs. 0.17 ± 0.025 mmol/L, p = 0.02). There was no evidence of insulin resistance evaluated by the homeostatic model assessment of insulin resistance in both groups studied. Conclusions: Our findings provide evidence that impairments in intrahepatic TRβ signaling due to mutations of the THRB gene can lead to hepatic steatosis, which emphasizes the influence of TH in the liver metabolism of lipids and provides a rationale for the development TRβ-selective thyromimetics. Consequently, new molecules with a very high TRβ affinity and hepatic selectivity have been developed for the treatment of lipid-associated hepatic disorders, particularly nonalcoholic fatty liver disease.
引用
- Chaves C, Bruinstroop E, Refetoff S, et al. Increased Hepatic Fat Content in Patients with Resistance to Thyroid Hormone Beta. Thyroid. 2021. PMID: 33353459. doi:10.1089/thy.2020.0651
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。